AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11322160 — intervention group
Group type: COMPARATOR
Intervention: Original functional obstacle course (FOC)
Number of subjects: 36
Study 9162610 — intervention group
Group type: EXPERIMENTAL
Intervention: IRS-1 Gly(972)Arg mutation (n = 9)
Number of subjects: 93
Study 9162610 — intervention group
Group type: EXPERIMENTAL
Intervention: IRS-1 Ala(513)Pro mutation (n = 5)
Number of subjects: 93
Study 9162610 — intervention group
Group type: EXPERIMENTAL
Intervention: Either one or both mutations (n = 13)
Number of subjects: 93
Study 9162610 — intervention group
Group type: COMPARATOR
Intervention: No mutations (n = 80)
Number of subjects: 93
Study 1343079 — intervention group
Group type: EXPERIMENTAL
Intervention: delta‐prednisone (1 mg/kg per day per os for 2 weeks)
Number of subjects: 168
Study 1343079 — intervention group
Group type: COMPARATOR
Intervention: Control (no steroids)
Number of subjects: 168
Study 6698348 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (1.2 g/kg) administered during three hours with cimetidine
Number of subjects: 10
Study 6698348 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (1.2 g/kg) administered during three hours without cimetidine
Number of subjects: 10
Study 6698348 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol (1.2 g/kg) with cimetidine
Number of subjects: 10
Study 6698348 — intervention group
Group type: COMPARATOR
Intervention: Ethanol (1.2 g/kg) without cimetidine
Number of subjects: 10
Study 6698348 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine administration
Number of subjects: 10
Study 28277426 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI)
Number of subjects: 12
Study 28277426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30252786 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalomedullary hip screws (CMHS)
Number of subjects: 14415
Study 30252786 — intervention group
Group type: COMPARATOR
Intervention: Sliding hip screws (SHS)
Number of subjects: 14415
Study 27215502 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycopyrrolate (GLY) 15.6 μg twice daily (b.i.d.)
Number of subjects: 511
Study 27215502 — intervention group
Group type: COMPARATOR
Intervention: Indacaterol (IND) 75 μg once daily (q.d.)
Number of subjects: 511
Study 24367959 — intervention group
Group type: EXPERIMENTAL
Intervention: Model right hand
Number of subjects: 21
Study 24367959 — intervention group
Group type: COMPARATOR
Intervention: Person's right hand
Number of subjects: 21
Study 24367959 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 21
Study 22752776 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous BT088 (200 IU, 0.4 mL)
Number of subjects: 31
Study 22752776 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular BT088 (200 IU, 0.4 mL)
Number of subjects: 31
Study 22752776 — intervention group
Group type: COMPARATOR
Intervention: Control group not applicable
Number of subjects: 31
Study 20471313 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS (transcranial direct current stimulation) at 400μA perception threshold
Number of subjects: 0
Study 20471313 — intervention group
Group type: EXPERIMENTAL
Intervention: tRNS (transcranial random noise stimulation) at 1200μA perception threshold
Number of subjects: 0
Study 20471313 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 0
Study 20471313 — intervention group
Group type: COMPARATOR
Intervention: Non-stimulation trials
Number of subjects: 0
Study 18342647 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive (COC)
Number of subjects: 534
Study 18342647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 534
Study 15929960 — intervention group
Group type: EXPERIMENTAL
Intervention: Palatal surgery (specific type not detailed)
Number of subjects: 35
Study 12239650 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic antireflux surgery (LARS) with major depression (MD)
Number of subjects: 38
Study 12239650 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic antireflux surgery (LARS) without major depression (non-MD)
Number of subjects: 38
Study 12239650 — intervention group
Group type: EXPERIMENTAL
Intervention: Nissen fundoplication
Number of subjects: 38
Study 12239650 — intervention group
Group type: EXPERIMENTAL
Intervention: Toupet fundoplication
Number of subjects: 38
Study 12239650 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic antireflux surgery (LARS)
Number of subjects: 38
Study 10233488 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 383
Study 10233488 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 383
Study 10233488 — intervention group
Group type: COMPARATOR
Intervention: Pharmacotherapy
Number of subjects: 383
Study 8919896 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast injection during the application of 20 cm H2O positive airway pressure for 5 s (Manoeuvre I)
Number of subjects: 80
Study 8919896 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrast injection during ventilation with PEEP (15 cm H2O), a tidal volume of 1,200 ml, and a respiratory rate of 6/min (Manoeuvre II)
Number of subjects: 80
Study 1907075 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate ingestion (105 grams total in 1050 millilitres solution)
Number of subjects: 9
Study 1907075 — intervention group
Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 9
Study 1907075 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate ingestion
Number of subjects: 9
Study 31831473 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine visit using Diabetic (intervention cohort)
Number of subjects: 379
Study 31831473 — intervention group
Group type: COMPARATOR
Intervention: Face‐to‐face visits (control cohort)
Number of subjects: 379
Study 31831473 — intervention group
Group type: COMPARATOR
Intervention: Control cohort (face‐to‐face visits)
Number of subjects: 379
Study 31831473 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention cohort (telemedicine visit)
Number of subjects: 379
Study 31831473 — intervention group
Group type: EXPERIMENTAL
Intervention: Both cohorts
Number of subjects: 379
Study 31060559 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg thiamine
Number of subjects: 130
Study 31060559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 29238262 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported exercise group (SE; CE plus upper back, neck, and shoulder exercises)
Number of subjects: 20
Study 29238262 — intervention group
Group type: COMPARATOR
Intervention: Conventional low back exercise group (CE)
Number of subjects: 20
Study 25815454 — intervention group
Group type: EXPERIMENTAL
Intervention: SPI-guided analgesia
Number of subjects: 45
Study 25815454 — intervention group
Group type: COMPARATOR
Intervention: Conventional analgesia
Number of subjects: 45
Study 23249984 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine with epinephrine
Number of subjects: 12
Study 23249984 — intervention group
Group type: COMPARATOR
Intervention: 1% plain lidocaine
Number of subjects: 12
Study 21425573 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated medical protocol (Chinese medical therapy plus conventional Western medical treatment)
Number of subjects: 606
Study 21425573 — intervention group
Group type: COMPARATOR
Intervention: Conventional Western medical treatment plus placebo
Number of subjects: 606
Study 21094432 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy School Ethos intervention
Number of subjects: 0
Study 21094432 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-mediation or motivational sessions
Number of subjects: 0
Study 21094432 — intervention group
Group type: EXPERIMENTAL
Intervention: Participation in planning or delivering intervention activities
Number of subjects: 0
Study 21094432 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 0
Study 17233787 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg methyltestosterone (MT)
Number of subjects: 10
Study 17233787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 15147112 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Group Therapy (CBGT)
Number of subjects: 57
Study 15147112 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 57
Study 11772706 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress management intervention
Number of subjects: 25
Study 11772706 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 25
Study 10518859 — intervention group
Group type: EXPERIMENTAL
Intervention: New and Improved Colgate Tartar Control Fluoride Toothpaste with Micro‐Cleaning Crystals
Number of subjects: 73
Study 10518859 — intervention group
Group type: COMPARATOR
Intervention: Colgate Tartar Control Fluoride Toothpaste with Micro‐Cleaning Crystals
Number of subjects: 73
Study 7814285 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg/day itraconazole (once daily)
Number of subjects: 7
Study 7814285 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg/day itraconazole (twice daily)
Number of subjects: 7
Study 2642622 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-hypnosis with specific suggestions for control of saliva immunoglobulins (Group B)
Number of subjects: 57
Study 2642622 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-hypnosis with permission to increase immune substances in saliva (Group A)
Number of subjects: 57
Study 2642622 — intervention group
Group type: COMPARATOR
Intervention: No instructions but received equal attention time (Group C)
Number of subjects: 57
Study 824298 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg TRH taken twice daily for four weeks
Number of subjects: 0
Study 824298 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-20 mg TRH taken twice daily for five days
Number of subjects: 0
Study 824298 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31595489 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg at night for 7 days
Number of subjects: 210
Study 31595489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 210
Study 31595489 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 210
Study 30848791 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP (4 pmol/kg/min)
Number of subjects: 17
Study 30848791 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 (1 pmol/kg/min)
Number of subjects: 17
Study 30848791 — intervention group
Group type: EXPERIMENTAL
Intervention: GIP + GLP-1 (4 and 1 pmol/kg/min, respectively)
Number of subjects: 17
Study 30848791 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 17
Study 30848791 — intervention group
Group type: EXPERIMENTAL
Intervention: OGTT (50-g oral glucose tolerance test)
Number of subjects: 17
Study 26621050 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm strength training (8-week program, 23 sessions)
Number of subjects: 42
Study 26279104 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous PTNS (voltage pulse intensity of 0 to 10 mA, pulse width of 200 μs, frequency of 20 Hz, 30 min weekly for 12 weeks)
Number of subjects: 40
Study 26279104 — intervention group
Group type: COMPARATOR
Intervention: Sham group (no stimulation, patch electrodes applied)
Number of subjects: 40
Study 23649787 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Engagement and Planning (CEP)
Number of subjects: 1246
Study 23649787 — intervention group
Group type: COMPARATOR
Intervention: Resources for Services (RS)
Number of subjects: 1246
Study 21719935 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (n=23)
Number of subjects: 44
Study 21719935 — intervention group
Group type: COMPARATOR
Intervention: Control group (unsupplemented, n=21)
Number of subjects: 44
Study 21719935 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E to lipids ratio
Number of subjects: 44
Study 19376270 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial-experienced participants
Number of subjects: 116
Study 19376270 — intervention group
Group type: COMPARATOR
Intervention: Trial-naïve participants
Number of subjects: 116
Study 16432272 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk thistle (900 mg) for 14 days
Number of subjects: 0
Study 16432272 — intervention group
Group type: EXPERIMENTAL
Intervention: Black cohosh (80 mg) for 14 days
Number of subjects: 0
Study 16432272 — intervention group
Group type: COMPARATOR
Intervention: Rifampin (600 mg) for 7 days
Number of subjects: 0
Study 16432272 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin (1000 mg) for 7 days
Number of subjects: 0
Study 12891970 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranet-based guidelines
Number of subjects: 12
Study 12891970 — intervention group
Group type: COMPARATOR
Intervention: Control (no guidelines)
Number of subjects: 12
Study 11204315 — intervention group
Group type: EXPERIMENTAL
Intervention: CA 125 serum levels
Number of subjects: 36
Study 11204315 — intervention group
Group type: COMPARATOR
Intervention: ESR
Number of subjects: 36
Study 11204315 — intervention group
Group type: COMPARATOR
Intervention: CRP
Number of subjects: 36
Study 8671102 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction by practice assistants after the first video; 25 patients received instruction from trained practice assistants who had followed a one evening course about inhaler instruction.
Number of subjects: 48
Study 8671102 — intervention group
Group type: COMPARATOR
Intervention: Control group (no instruction) consisting of 23 patients who did not receive instruction.
Number of subjects: 48
Study 1288512 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic preparation (900 mg of garlic powder standardized as to 1.3% alliin)
Number of subjects: 98
Study 1288512 — intervention group
Group type: COMPARATOR
Intervention: Bezafibrate (600 mg)
Number of subjects: 98
Study 3875454 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory pressure support during spontaneous ventilation (IPSSV)
Number of subjects: 26
Study 3875454 — intervention group
Group type: COMPARATOR
Intervention: Conventional ventilation (CV)
Number of subjects: 26
Study 30862293 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated depression-alcohol misuse cognitive-behaviour therapy (CBT)
Number of subjects: 220
Study 30862293 — intervention group
Group type: COMPARATOR
Intervention: Alcohol/depression single-focused interventions
Number of subjects: 220
Study 30862293 — intervention group
Group type: COMPARATOR
Intervention: Brief interventions
Number of subjects: 220
Study 30416018 — intervention group
Group type: EXPERIMENTAL
Intervention: 2008-2009 Fluzone®
Number of subjects: 100
Study 30416018 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluarix®
Number of subjects: 100
Study 27756485 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine (Merck Adenovirus‐5 Gag/Pol/Nef HIV‐1 subtype‐B vaccine)
Number of subjects: 43
Study 27756485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 27756485 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine
Number of subjects: 43
Study 23475226 — intervention group
Group type: EXPERIMENTAL
Intervention: Yo-Yo Intermittent Recovery Test Level 1 (Yo-YoIR1)
Number of subjects: 14
Study 23475226 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-15 Intermittent Fitness Test (30-15IFT)
Number of subjects: 14
Study 22307266 — intervention group
Group type: EXPERIMENTAL
Intervention: Upfront zoledronic acid (4 mg intravenously every 6 months)
Number of subjects: 189
Study 22307266 — intervention group
Group type: COMPARATOR
Intervention: Delayed zoledronic acid (4 mg intravenously every 6 months)
Number of subjects: 189
Study 20601739 — intervention group
Group type: EXPERIMENTAL
Intervention: Sago-soy supplementation (52.5 g carbohydrate and 15 g protein)
Number of subjects: 8
Study 20601739 — intervention group
Group type: EXPERIMENTAL
Intervention: Sago supplementation (60 g carbohydrate)
Number of subjects: 8
Study 20601739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 18479779 — intervention group
Group type: EXPERIMENTAL
Intervention: Confederate ate a large amount of M&Ms
Number of subjects: 102
Study 18479779 — intervention group
Group type: COMPARATOR
Intervention: Confederate ate a small amount of M&Ms
Number of subjects: 102
Study 18479779 — intervention group
Group type: COMPARATOR
Intervention: Confederate ate no M&Ms
Number of subjects: 102
Study 18479779 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal-weight appearance condition
Number of subjects: 102
Study 18479779 — intervention group
Group type: COMPARATOR
Intervention: Slim appearance condition
Number of subjects: 102
Study 15760532 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined decompression operation (tentorium cerebelli incised 2-4 cm, bone flap craniectomy decompression (10-15)cm x (15-17)cm)
Number of subjects: 97
Study 15760532 — intervention group
Group type: COMPARATOR
Intervention: Conventional temporoparietal craniectomy
Number of subjects: 97
Study 12226784 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time visual kinematic feedback
Number of subjects: 12
Study 12226784 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbal instruction
Number of subjects: 12
Study 12226784 — intervention group
Group type: COMPARATOR
Intervention: Free walking
Number of subjects: 12
Study 10470769 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in ordering practice: No standing orders for routine daily morning chest radiographs; each radiograph requires a written order and clinical indication.
Number of subjects: 3727
Study 10470769 — intervention group
Group type: COMPARATOR
Intervention: Routine daily chest radiographs (control phase)
Number of subjects: 3727
Study 8530649 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin infusion of 256 mIU/min for 2 h
Number of subjects: 16
Study 8530649 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 16
Study 2195152 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste and oral rinse containing sanguinaria extract and zinc chloride
Number of subjects: 60
Study 2195152 — intervention group
Group type: COMPARATOR
Intervention: Placebo products
Number of subjects: 60
Study 399943 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiation therapy combined with surgical excision
Number of subjects: 0
Study 399943 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant radiation therapy
Number of subjects: 0
Study 30875354 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous noninvasive blood pressure monitoring
Number of subjects: 312
Study 30875354 — intervention group
Group type: COMPARATOR
Intervention: Routine vital-sign assessments
Number of subjects: 312
Study 29559771 — intervention group
Group type: EXPERIMENTAL
Intervention: FDC of telmisartan 80 mg and S-amlodipine 5 mg (CKD-828)
Number of subjects: 48
Study 29559771 — intervention group
Group type: COMPARATOR
Intervention: Coadministration of individual agents (telmisartan and S-amlodipine)
Number of subjects: 48
Study 26827074 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg/day
Number of subjects: 970
Study 26827074 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 1.25 mg/day
Number of subjects: 970
Study 26827074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 970
Study 24506809 — intervention group
Group type: EXPERIMENTAL
Intervention: Inorganic sunscreen (SPF 50)
Number of subjects: 15
Study 24506809 — intervention group
Group type: EXPERIMENTAL
Intervention: Foundation (SPF 50)
Number of subjects: 15
Study 24506809 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-blocking plaster
Number of subjects: 15
Study 24506809 — intervention group
Group type: COMPARATOR
Intervention: Control (unprotected)
Number of subjects: 15
Study 21067832 — intervention group
Group type: EXPERIMENTAL
Intervention: L-citrulline 5.6g/day for 7 days
Number of subjects: 15
Study 21067832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 20226331 — intervention group
Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 844
Study 16821119 — intervention group
Group type: EXPERIMENTAL
Intervention: ICE-guided transcatheter closure
Number of subjects: 25
Study 16821119 — intervention group
Group type: COMPARATOR
Intervention: Control (non-ICE-guided transcatheter closure)
Number of subjects: 25
Study 16222060 — intervention group
Group type: EXPERIMENTAL
Intervention: Octreotide (100 mug subcutaneously)
Number of subjects: 26
Study 16222060 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 14589718 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal Conditions (NC)
Number of subjects: 0
Study 14589718 — intervention group
Group type: COMPARATOR
Intervention: Faking Bad (FB)
Number of subjects: 0
Study 9878017 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-drug therapy
Number of subjects: 12
Study 9878017 — intervention group
Group type: COMPARATOR
Intervention: Drug-containing arms of the cultures
Number of subjects: 12
Study 8573357 — intervention group
Group type: EXPERIMENTAL
Intervention: PMR visits (experimental group)
Number of subjects: 40
Study 8573357 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training or special treatment)
Number of subjects: 40
Study 1957129 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime (8 mg/kg/day for 7 days)
Number of subjects: 397
Study 1957129 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor (40 mg/kg/day for 7 days)
Number of subjects: 397
Study 1957129 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefixime
Number of subjects: 397
Study 1957129 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor
Number of subjects: 397
Study 7044529 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (TAM) alone
Number of subjects: 91
Study 7044529 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen plus aminoglutethimide (TAM plus AG)
Number of subjects: 91
Study 7044529 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (AG) in patients with prior tamoxifen exposure
Number of subjects: 91
Study 30497085 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceval sutureless bioprosthesis
Number of subjects: 1234
Study 30497085 — intervention group
Group type: COMPARATOR
Intervention: Standard sutured stented bioprosthetic aortic valve
Number of subjects: 1234
Study 31639022 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative patients
Number of subjects: 85